2021
DOI: 10.1016/j.eurpolymj.2020.110239
|View full text |Cite
|
Sign up to set email alerts
|

Halomonas levan-coated phospholipid based nano-carrier for active targeting of A549 lung cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…Furthermore, levan was used to coat lipid nanoparticles containing paclitaxel, resulting in controlled release of the drug over a period of six hours. These coated nanoparticles exhibited increased toxicity to human A549 lung cancer cells compared to uncoated nanoparticles, potentially due to the presence of levan in the coating [ 135 ]. Recent research on antitumor therapy reports the creation of nanoparticles with an intrinsic targeting ability to deliver anticancer drugs.…”
Section: Levan Nanocarriers Developmentmentioning
confidence: 99%
“…Furthermore, levan was used to coat lipid nanoparticles containing paclitaxel, resulting in controlled release of the drug over a period of six hours. These coated nanoparticles exhibited increased toxicity to human A549 lung cancer cells compared to uncoated nanoparticles, potentially due to the presence of levan in the coating [ 135 ]. Recent research on antitumor therapy reports the creation of nanoparticles with an intrinsic targeting ability to deliver anticancer drugs.…”
Section: Levan Nanocarriers Developmentmentioning
confidence: 99%